-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下：我們維持目標價125美元，相當於2027年每股盈餘預期值的20倍。我們認為，儘管ABT透過收購Exact Sciences (EXAS)增強了策略性產品組合，且擁有強勁的創新研發管線，但這一目標價仍低於ABT的歷史平均水準。我們將2026年每股盈餘預期從5.76美元調整至5.56美元，以計入EXAS收購帶來的稀釋效應，維持2027年每股盈餘預期為6.26美元。 ABT在第一季實現了多項重要的研發管線里程碑，包括提前核准並推出兩款PFA導管（Volt在美國上市，Duo在歐洲上市）、完成Catalyst左心耳封堵器試驗的患者招募，以及利寶利伐沙班（Libre）對接受基礎胰島素治療的2型糖尿病患者俱有積極療效的試驗結果。 我們對EXAS的整合仍持樂觀態度，整合已於3月下旬完成，比預期略早。這項交易使ABT成為美國價值約600億美元的癌症篩檢和精準腫瘤診斷市場的領導者，該市場是醫療保健領域成長最快的細分市場之一。
Related Articles
Australia
Sector Update: Financial Stocks Softer Late Afternoon
Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.
$APO$ARES$GS$MRSH$SCHW
Japan
US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal
US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.
$^DJI$^IXIC$^SPX
Sectors
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.
$ABT$GILD$HIMS$QDEL